Citius Pharmaceuticals, Inc. (CTXR) vs Optimi Health Corp. (OPTH)
A side-by-side comparison of Citius Pharmaceuticals, Inc. and Optimi Health Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTXR
Citius Pharmaceuticals, Inc.
$0.49HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
OPTH
Optimi Health Corp.
$4.19HealthcareDelayed quote: Oct 6, 2026, 3:26 PM EDT
Total return — CTXR vs OPTH
growth of $100 · dividends reinvested · last 6yCTXR -98.8% (-52.3%/yr)OPTH -74.5% (-20.4%/yr)OPTH compounded faster over this window
Log scale — wide-divergence pair
CTXR OPTH
CTXR vs OPTH: by the numbers
- •OPTH is the larger company ($13M vs $13M market cap).
- •Both run net losses; CTXR's is the smaller (-651.27% vs -3972.87% net margin).
Metrics side by side
Valuation
| Metric | CTXR | OPTH |
|---|---|---|
| P/S ratio | 1.88 | 108.46 |
| P/B ratio | 0.20 | 1.09 |
Profitability
| Metric | CTXR | OPTH |
|---|---|---|
| Gross margin | 0.00% | -486.44% |
| Operating margin | 0.00% | -1062.29% |
| Net margin | -651.27% | -3972.87% |
| ROE | -69.47% | -39.76% |
| ROIC | -67.62% | -28.72% |
Growth (annualized)
| Metric | CTXR | OPTH |
|---|---|---|
| Total return CAGR (5Y) | -60.04% | -21.80% |
Frequently asked
- How have CTXR and OPTH total returns compared?
- Over the past 5 years, CTXR delivered -60.04% and OPTH delivered -21.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.